OUR LATEST & GREATEST

AI is becoming an integral part of how life sciences research operates across wet labs vs dry labs. As experiments, data generation, and analysis compress into faster feedback loops, AI increasingly influences what gets tested and when…

Life sciences onshoring is emerging as a practical solution to persistent supply chain shortages, strengthening drug availability, quality oversight, and long‑term resilience.

Explore how decentralized clinical trials have impacted R&D within the life sciences industry. Learn the benefits and challenges of DCTs.

Pharma AI is reshaping drug discovery, development, and delivery with unprecedented speed. Explore five major breakthroughs driving transformation across R&D, formulation, and patient outcomes.

Digital twins are reshaping drug development, clinical trials, and pharmaceutical manufacturing. Learn how this technology accelerates innovation—and why life sciences organizations are rapidly adopting it.

Explore how innovation in life sciences is accelerating across pharmaceuticals, biotechnology, clinical research, and medical devices—and what the future holds for this rapidly evolving sector.

Discover ten advances showing how AI is reshaping drug discovery, clinical trials, genomics, biomarker discovery, and more across the life sciences sector.

Pharmaceutical manufacturing expansion is reshaping the industry and shifting priorities. Here’s what pharma leaders must understand to stay competitive.

Explore how AI-enabled discovery, personalization, sustainability, pricing pressures, and the looming patent cliff are shaping the future of the pharmaceutical industry.

Let's dive into how the Big Beautiful Bill could affect the healthcare and life sciences industries.

The pharmaceutical industry is facing lab challenges that continue to stall innovation in research & development. Discover the top 7 reasons.

As more companies integrate AI into their processes, it’s important to understand the benefits and risks of AI innovation in pharma R&D.